Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOMUSTINE vs LORAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOMUSTINE vs LORAZEPAM: Safety Overview

Metric LOMUSTINE LORAZEPAM
Total FAERS Reports 1,614 33,404
Deaths Reported 431 6,187
Death Rate 26.7% 18.5%
Hospitalizations 418 15,431
Average Patient Age 45.5 yrs 49.8 yrs
% Female Patients 42.5% 60.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Carnegie Pharmaceuticals LLC Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription